← Back to headlines
Anavex Life Sciences reports GAAP EPS of -$0.08
The biotech company reported a loss per share of $0.08 under GAAP accounting standards for its latest financial period.
25 Aug, 12:04 — 25 Aug, 12:04
Sources
Showing 1 of 1 sources
The biotech company reported a loss per share of $0.08 under GAAP accounting standards for its latest financial period.
